Glaucoma News

VANCOUVER, British Columbia — Matus Rehak, MD, PhD, discusses his poster presentation regarding the impact of blood pressure and blood gas parameters on macular perfusion measured by OCT angiography at the Association for Research in Vision and Ophthalmology meeting.

OTX-TP, a glaucoma treatment candidate from Ocular Therapeutix, failed to meet its phase 3 primary endpoint of statistically significant superiority in mean IOP reduction, according to a press release.

VANCOUVER, British Columbia — Yehia Hashad, MD, Allergan’s senior vice president and head of global development, discusses a recent study that found the company’s sustained release bimatoprost implant provided good IOP control and visual field preservation in patients with open-angle glaucoma.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Nathan M. Radcliffe, MD, discusses a new tonometer tip that gives accurate IOP measurements in the eye regardless of corneal hysteresis, corneal thickness and other variables that have previously affected Goldmann tonometers.

VANCOUVER, British Columbia — Caser Luo, MD, discusses global safety data for Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) at the Association for Research in Vision and Ophthalmology meeting. In phase 4 post-market studies, the rate of IOP-related incisional surgery was “extremely low,” he said.

VANCOUVER, British Columbia — Michael C. Giovingo, MD, of Cook County Health in Chicago, discusses two studies presented at the Association for Research in Vision and Ophthalmology meeting.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Nathan M. Radcliffe, MD, discusses the generic dorzolamide shortage that has not been explained by generic manufacturers and how it is having a deleterious effect on patients with glaucoma who are unable to get the medication.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Steven M. Silverstein, MD, discusses his long-running experience using endoscopic cyclophotocoagulation to lower IOP in patients with glaucoma.

SAN DIEGO — Early study results have shown a meaningful decrease in IOP in glaucoma patients treated with OTX-TIC, an intracameral travoprost implant, according to a speaker.

SAN DIEGO — No safety concerns were identified after intracameral injection of a steroid, NSAID and antibiotic combination in glaucoma patients undergoing cataract surgery with implantation of a supraciliary shunt, according to a speaker.